No one can argue that this is not a legitimate, value adding announcement.
Should see a step change in sales next quarter. Just need the asset sale to get a few more 4c's under our belt before the next cap raise.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-92
-
- There are more pages in this discussion • 476 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.09 |
Change
0.000(0.00%) |
Mkt cap ! $318.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1109 | $15.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 779 | 1 |
View Market Depth
| Last trade - 09.02am 21/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable